TITLE

Postrecurrence survival in patients with stage I non-small cell lung cancer

AUTHOR(S)
Nakagawa, Tatsuo; Okumura, Norihito; Ohata, Keiji; Igai, Hitoshi; Matsuoka, Tomoaki; Kameyama, Kotaro
PUB. DATE
September 2008
SOURCE
European Journal of Cardio-Thoracic Surgery;Sep2008, Vol. 34 Issue 3, p499
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Postoperative recurrence is a major obstacle to achieving a cure and long-term survival in patients with non-small lung cancer. However, prognostic factors and the efficacy of therapy after recurrence remain controversial. We evaluated the clinical outcomes of patients with resected lung cancer for postrecurrence prognostic factors. Methods: Patients who underwent complete resection with systematic lymph node dissection for stage I non-small cell lung cancer were selected. Cases of low-grade malignancy, preoperative therapy, history of previous malignancy or death within 30 days of operation were excluded. A total of 397 patients were retrospectively reviewed. Results: Out of 87 patients who had recurrence after surgery, 45 had symptoms at the initial recurrence. The initial recurrent site was local in 30 patients and distant in 57. Single-site recurrence was detected in 48 patients and multiple-site recurrence was seen in 39. The recurrent site was the ipsilateral thorax in 49 patients, the contralateral thorax in 32, the cervico-mediastinum in 15, brain in 12 and bone in 11. Surgery was performed in 20 patients, whereas non-surgical therapy was performed in 55 (chemotherapy, 16; radiation therapy, 33; chemo-radiation therapy, 6). Prognostic analysis of factors related to recurrent status demonstrated that symptoms at the initial recurrence, cervico-mediastinal metastasis, liver metastasis and postrecurrence therapy were significant prognostic factors in both univariate and multivariate analysis. Conclusions: Symptoms at the initial recurrence, cervico-mediastinal metastasis and liver metastasis were worse prognostic factors after recurrence. Postrecurrence therapy for the initial recurrence may prolong survival after recurrence.
ACCESSION #
33887327

 

Related Articles

  • Identification of risk factors and characteristics of supraclavicular lymph node metastasis in patients with small cell lung cancer. Feng, Zhen-Xing; Zhao, Lu-Jun; Guan, Yong; Sun, Yao; Meng, Mao-Bin; Ji, Kai; Wang, Ping // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Thoracic radiotherapy provides a survival benefit in patients with limited-stage disease of small cell lung cancer (LS-SCLC), but inclusion and exclusion of prophylactic irradiation of the supraclavicular area are still controversial. This study analyses the risk factors and characteristics of...

  • Transcervical extended mediastinal lymphadenectomy–the new operative technique and early results in lung cancer staging. Kużdżał, Jarosław; Zieliński, Marcin; Papla, Bolesław; Szlubowski, Artur; Hauer, Łukasz; Nabiałek, Tomasz; Sośnicki, Witold; Pankowski, Juliusz // European Journal of Cardio-Thoracic Surgery;Mar2005, Vol. 27 Issue 3, p384 

    Abstract: Objective: Mediastinal staging is one of the most important problems in thoracic surgery. Although the pathological examination is a generally accepted standard, none of the currently used techniques enables complete removal of all lymph node stations of the mediastinum. The aim of the...

  • Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer. Melek, Huseyin; Gunluoglu, Mehmet Zeki; Demir, Adalet; Akin, Hasan; Olcmen, Aysun; Dincer, Seyyit Ibrahim // European Journal of Cardio-Thoracic Surgery;Feb2008, Vol. 33 Issue 2, p294 

    Abstract: Objective: Positron emission tomography (PET) is used increasingly in staging of non-small cell lung cancer (NSCLC) as a non-invasive tool. The role of the PET in mediastinal lymphatic staging of NSCLC is not clear. We aimed to demonstrate the efficacy of PET in determining mediastinal...

  • Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Sasaki, Hidefumi; Yukiue, Haruhiro; Mizuno, Kotaro; Sekimura, Atsushi; Konishi, Akimitsu; Yano, Motoki; Kaji, Masahiro; Kiriyama, Masanobu; Fukai, Ichiro; Yamakawa, Yosuke; Fujii, Yoshitaka // International Journal of Clinical Oncology;Apr2003, Vol. 8 Issue 2, p0079 

    Background: Using an enzyme immunoassay for epidermal growth factor receptor (EGFR), we investigated whether serum EGFR levels could be used as predictors of the development and extent of lung cancer. Methods: The study included 106 lung cancer patients and 16 patients with nonmalignant thoracic...

  • Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer. Gotoh, Hajimu; Kanomata, Naoki; Yoshimura, Masahiro; Ohno, Yoshiharu; Moriya, Takuya; Ohbayashi, Chiho // Medical Molecular Morphology;Sep2009, Vol. 42 Issue 3, p162 

    Nodal staging is a crucial factor in choosing the treatment option for non-small cell lung cancer (NSCLC). However, so far as we know, a computer-based histomorphometric analysis of lymph nodes in NSCLC has never been developed. We studied 299 surgically resected lymph nodes from 108 patients...

  • MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Li, Jipeng; Song, Yulan; Wang, Yiping; Luo, Jianping; Yu, Wanjun // Molecular & Cellular Biochemistry;Aug2013, Vol. 380 Issue 1/2, p277 

    Recent studies have implied that miRNAs act as crucial modulators for epithelial-to-mesenchymal transition (EMT). We found that miR-148a is significantly downregulated in non-small cell lung cancer (NSCLC) compared to adjacent non-cancerous lung tissues, and the downregulated miR-148a was...

  • Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases. Wei Jiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Jian Zhou; Meng-Su Zeng; Jian-Ying Zhang; Yi-Xing Chen; Yun-Shan Tan // Journal of Cancer Research & Clinical Oncology;Sep2010, Vol. 136 Issue 9, p1323 

    To evaluate the role of radiotherapy for patients with resected intrahepatic cholangiocarcinoma with concurrent macroscopic abdominal lymph node metastases. We identified 90 patients with resected intrahepatic cholangiocarcinoma and concurrent regional lymph node metastases treated between 1999...

  • Identifying patients with peripheral-type early non-small cell lung cancer (T1N0M0) for whom irradiation of the primary focus alone could lead to successful treatment. Fuwa, N.; Daimon, T.; Mitsudomi, T.; Yatabe, Y.; Kodaira, T.; Tachibana, H.; Nakamura, T.; Kato, T.; Sato, Y. // British Journal of Radiology;Oct2008, Vol. 81 Issue 970, p815 

    We investigated the indication of radiotherapy in operable patients with peripheral-type early non-small cell lung cancer (T1N0M0 (TNM staging in 1997)). The subjects comprised 396 patients with non-small cell lung cancer in whom the clinical stage was evaluated as IA. We examined age, gender,...

  • Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Nestle, Ursula; Schaefer-Schuler, Andrea; Kremp, Stephanie; Groeschel, Andreas; Hellwig, Dirk; Rübe, Christian; Kirsch, Carl-Martin // European Journal of Nuclear Medicine & Molecular Imaging;Apr2007, Vol. 34 Issue 4, p453 

    FDG PET is increasingly used in radiotherapy planning. Recently, we demonstrated substantial differences in target volumes when applying different methods of FDG-based contouring in primary lung tumours (Nestle et al., J Nucl Med 2005;46:1342–8). This paper focusses on FDG-positive...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics